The pharmacodynamics of antiplatelet compounds in thrombosis treatment
Authors:
- 26 April 2016
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Drug Metabolism & Toxicology
- Vol. 12 (6) , 615-632
Abstract
Introduction: As it is importance to understand the involvement of platelets in the initiation and propagation of thrombosis, antiplatelet drugs have come to the forefront of atherothrombotic disease treatment. Dual antiplatelet therapy of aspirin plus clopidogrel has its benefits, but it also has its limitations with regard to its pharmacologic properties and adverse effects. For these reasons, within the last decade or so, the investigation of novel antiplatelet agents has prospered. Areas covered: In this review, we discuss the unique pharmacodynamic properties of several antiplatelet drugs with their possible potential molecular of mechanisms on inhibiting platelet aggregation. Expert opinion: Considering multiple synergetic pathways of platelet activation and their close interplay with coagulation, the current treatment strategies are not only based on platelet inhibition, they also rely on the attenuation of procoagulant activity, inhibition of thrombin generation, and enhancement of clot dissolution. Current guidelines recommend various antiplatelet agents in addition to aspirin for patients with acute coronary syndromes. The advantages of these agents, as repute mortality, may be associated with off-target effects of the drug. Hence, further studies are required to facilitate the physician’s choice of the most appropriate antiplatelet agents for each patient for thrombosis treatment.Keywords
This publication has 126 references indexed in Scilit:
- A Platelet Acquired Storage Pool Disorder Associated with Tamoxifen TherapyCase Reports in Hematology, 2012
- Determination of resveratrol and its sulfate and glucuronide metabolites in plasma by LC–MS/MS and their pharmacokinetics in dogsJournal of Pharmaceutical and Biomedical Analysis, 2012
- Xanthohumol, a Prenylated Flavonoid from Hops (Humulus lupulus), Prevents Platelet Activation in Human PlateletsEvidence-Based Complementary and Alternative Medicine, 2012
- A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 TrialEuropean Heart Journal, 2011
- P2Y12 inhibitors: differences in properties and mechanisms of action and potential consequences for clinical useEuropean Heart Journal, 2009
- Antiviral Activity of the Zinc Ionophores Pyrithione and Hinokitiol against Picornavirus InfectionsJournal of Virology, 2009
- Hinokitiol, a metal chelator derived from natural plants, suppresses cell growth and disrupts androgen receptor signaling in prostate carcinoma cell linesBiochemical and Biophysical Research Communications, 2006
- Pharmacokinetic and oral bioavailability of andrographolide from Andrographis paniculata fixed combination Kan Jang in rats and humanPhytomedicine, 2000
- Comparison of the relative activities of α-tocopherol and PMC on platelet aggregation and antioxidative activityLife Sciences, 1999
- KINETIN, A CELL DIVISION FACTOR FROM DEOXYRIBONUCLEIC ACID1Journal of the American Chemical Society, 1955